LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/PEEK Rods to Benefit From FDA Reclassification of Spinal Systems?
Spine

PEEK Rods to Benefit From FDA Reclassification of Spinal Systems?

April 3, 2017 2 min read Premium comments

Advertisement

PEEK Rods to Benefit From FDA Reclassification of Spinal Systems?
PEEK-OPTIMA Spinal Rod Components / Courtesy of Invibio Biomaterial Solutions
Secondary

The recent FDA reclassification of semi-rigid spinal stabilization systems from Class III to Class II means that new treatments are on the horizon. One such opportunity may come from UK-based Invibio Biomaterial Solutions, a company that provides PEEK-based biomaterial solutions.

As indicated in the March 8, 2017 news release, there may be “…a regulatory pathway to 510(k) clearance in the United States for innovative devices using PEEK-OPTIMA polymer based rods from Invibio Biomaterial Solutions (“Invibio”). When compared to rigid systems, semi-rigid PEEK-OPTIMA rods can deliver similar benefits to titanium and are strong enough to stabilize the spine. The FDA decision supports the safety of semi-rigid systems and provides greater options for surgeons who prefer more flexibility than traditional rigid pedicle screw systems to achieve fusion.”

“Invibio collaborated closely with medical device manufacturers and the FDA to provide clinical and biomechanical data in support of the use of semi-rigid PEEK-OPTIMA rods for spinal stabilization. The pioneering development and reclassification is expected to assist the medical profession in achieving progress in enhanced spinal fusion systems and procedures.”

“The down classification of PEEK-OPTIMA rods as a Class II technology for spinal fusion is a welcome and progressive development for the medical device market. Substantial evidence was presented in reaching this conclusion, including data from over 51,000 PEEK rod implantations. We now have a growing body of clinical evidence that systems based on Invibio´s PEEK-OPTIMA rods have clearly defined advantages over all-metal constructs and have the potential to drive the future of posterior spine stabilization,” commented John Devine, Invibio medical business director.

“PEEK-polymer solutions are widely recognized for spinal interbody fusion and are frequently used. The versatile PEEK-OPTIMA has a modulus close to that of human bone, and this allows it to be a natural bridge between very rigid metal implants, such as the titanium constructs, and more dynamic approaches. In fact, PEEK-polymer implants offer numerous benefits, including radiolucency, which of course metals don’t allow, while retaining the stability of titanium,” commented Dr. Thierry Desjardins, neurosurgeon (Cagnes-sur-Mer, France), who has been using PEEK-OPTIMA spinal rods since June 2011 and has always been reluctant to use too rigid a system as this could accelerate degeneration at adjacent spinal segments.

John Devine told OTW, “Spinal rods composed of metal are not without challenges, including, but not limited to, rod breakage, the loosening of screws, and accelerated degeneration at adjacent spinal segments. The high stiffness inherent in all-metal constructs is believed to contribute to these clinical challenges and negatively impact patient outcomes.”

“PEEK-OPTIMA polymer based stabilization, on the other hand, effectively functions as a ‘bridge’ approach. Rods made from the material have sufficient strength to reduce the range of motion in order to stabilize the treated segment, but possessing a modulus similar to that of cortical bone, they still allow physiological movement on adjacent upper and lower segments.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy